CN110692787A - 菊花六宝茶及其制备方法 - Google Patents
菊花六宝茶及其制备方法 Download PDFInfo
- Publication number
- CN110692787A CN110692787A CN201911119732.1A CN201911119732A CN110692787A CN 110692787 A CN110692787 A CN 110692787A CN 201911119732 A CN201911119732 A CN 201911119732A CN 110692787 A CN110692787 A CN 110692787A
- Authority
- CN
- China
- Prior art keywords
- chrysanthemum
- parts
- tea
- lotus
- sieving
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 235000007516 Chrysanthemum Nutrition 0.000 title claims abstract description 72
- 238000002360 preparation method Methods 0.000 title claims abstract description 9
- 244000269722 Thea sinensis Species 0.000 title claims abstract 13
- 240000005250 Chrysanthemum indicum Species 0.000 title 1
- 240000002853 Nelumbo nucifera Species 0.000 claims abstract description 43
- 235000006508 Nelumbo nucifera Nutrition 0.000 claims abstract description 43
- 235000006510 Nelumbo pentapetala Nutrition 0.000 claims abstract description 40
- 240000001008 Dimocarpus longan Species 0.000 claims abstract description 36
- 235000000235 Euphoria longan Nutrition 0.000 claims abstract description 36
- 244000037364 Cinnamomum aromaticum Species 0.000 claims abstract description 18
- 235000014489 Cinnamomum aromaticum Nutrition 0.000 claims abstract description 18
- 238000010298 pulverizing process Methods 0.000 claims abstract description 18
- 238000007873 sieving Methods 0.000 claims abstract description 18
- 241000723353 Chrysanthemum Species 0.000 claims abstract description 17
- 210000000582 semen Anatomy 0.000 claims abstract description 16
- 238000001035 drying Methods 0.000 claims abstract description 15
- 241000007126 Codonopsis pilosula Species 0.000 claims abstract description 14
- 238000004140 cleaning Methods 0.000 claims abstract description 12
- 241000628997 Flos Species 0.000 claims abstract description 11
- 239000002994 raw material Substances 0.000 claims abstract description 11
- 238000002156 mixing Methods 0.000 claims abstract description 8
- 239000000843 powder Substances 0.000 claims abstract description 8
- 241000756943 Codonopsis Species 0.000 claims abstract description 7
- 238000005520 cutting process Methods 0.000 claims abstract description 6
- 239000002245 particle Substances 0.000 claims abstract description 6
- 238000011049 filling Methods 0.000 claims abstract 2
- 239000011812 mixed powder Substances 0.000 claims 1
- 230000000694 effects Effects 0.000 abstract description 36
- 210000004185 liver Anatomy 0.000 abstract description 23
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 abstract description 12
- 201000010099 disease Diseases 0.000 abstract description 11
- 230000004438 eyesight Effects 0.000 abstract description 8
- 210000004072 lung Anatomy 0.000 abstract description 6
- 210000002784 stomach Anatomy 0.000 abstract description 6
- 230000032683 aging Effects 0.000 abstract description 5
- 239000003053 toxin Substances 0.000 abstract description 4
- 231100000765 toxin Toxicity 0.000 abstract description 4
- 231100000419 toxicity Toxicity 0.000 abstract description 2
- 230000001988 toxicity Effects 0.000 abstract description 2
- 244000189548 Chrysanthemum x morifolium Species 0.000 description 55
- 235000013616 tea Nutrition 0.000 description 55
- 241001122767 Theaceae Species 0.000 description 53
- 239000008280 blood Substances 0.000 description 29
- 210000004369 blood Anatomy 0.000 description 26
- 230000007812 deficiency Effects 0.000 description 19
- 239000000203 mixture Substances 0.000 description 19
- 239000003814 drug Substances 0.000 description 15
- 210000000952 spleen Anatomy 0.000 description 11
- 230000001603 reducing effect Effects 0.000 description 9
- 208000024891 symptom Diseases 0.000 description 9
- 208000002193 Pain Diseases 0.000 description 8
- 235000005911 diet Nutrition 0.000 description 8
- 235000013305 food Nutrition 0.000 description 8
- 230000036541 health Effects 0.000 description 8
- 230000036407 pain Effects 0.000 description 8
- 230000037213 diet Effects 0.000 description 7
- 229940079593 drug Drugs 0.000 description 7
- 239000003925 fat Substances 0.000 description 7
- 235000019197 fats Nutrition 0.000 description 7
- 230000006870 function Effects 0.000 description 7
- 241000272201 Columbiformes Species 0.000 description 6
- 230000036772 blood pressure Effects 0.000 description 6
- NOESYZHRGYRDHS-UHFFFAOYSA-N insulin Chemical compound N1C(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(NC(=O)CN)C(C)CC)CSSCC(C(NC(CO)C(=O)NC(CC(C)C)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CCC(N)=O)C(=O)NC(CC(C)C)C(=O)NC(CCC(O)=O)C(=O)NC(CC(N)=O)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CSSCC(NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2C=CC(O)=CC=2)NC(=O)C(CC(C)C)NC(=O)C(C)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2NC=NC=2)NC(=O)C(CO)NC(=O)CNC2=O)C(=O)NCC(=O)NC(CCC(O)=O)C(=O)NC(CCCNC(N)=N)C(=O)NCC(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC(O)=CC=3)C(=O)NC(C(C)O)C(=O)N3C(CCC3)C(=O)NC(CCCCN)C(=O)NC(C)C(O)=O)C(=O)NC(CC(N)=O)C(O)=O)=O)NC(=O)C(C(C)CC)NC(=O)C(CO)NC(=O)C(C(C)O)NC(=O)C1CSSCC2NC(=O)C(CC(C)C)NC(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CC(N)=O)NC(=O)C(NC(=O)C(N)CC=1C=CC=CC=1)C(C)C)CC1=CN=CN1 NOESYZHRGYRDHS-UHFFFAOYSA-N 0.000 description 6
- 230000001737 promoting effect Effects 0.000 description 6
- 235000018102 proteins Nutrition 0.000 description 6
- 102000004169 proteins and genes Human genes 0.000 description 6
- 108090000623 proteins and genes Proteins 0.000 description 6
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 6
- 244000077995 Coix lacryma jobi Species 0.000 description 5
- 241000196324 Embryophyta Species 0.000 description 5
- 206010019233 Headaches Diseases 0.000 description 5
- 240000002624 Mespilus germanica Species 0.000 description 5
- 235000017784 Mespilus germanica Nutrition 0.000 description 5
- 235000000560 Mimusops elengi Nutrition 0.000 description 5
- 206010033557 Palpitations Diseases 0.000 description 5
- 235000007837 Vangueria infausta Nutrition 0.000 description 5
- 208000002173 dizziness Diseases 0.000 description 5
- 230000035622 drinking Effects 0.000 description 5
- 231100000869 headache Toxicity 0.000 description 5
- 235000012907 honey Nutrition 0.000 description 5
- 230000001965 increasing effect Effects 0.000 description 5
- 230000002401 inhibitory effect Effects 0.000 description 5
- 150000002632 lipids Chemical class 0.000 description 5
- 239000000463 material Substances 0.000 description 5
- 229910052698 phosphorus Inorganic materials 0.000 description 5
- 230000037303 wrinkles Effects 0.000 description 5
- 206010008479 Chest Pain Diseases 0.000 description 4
- 206010051625 Conjunctival hyperaemia Diseases 0.000 description 4
- 206010020772 Hypertension Diseases 0.000 description 4
- XEEYBQQBJWHFJM-UHFFFAOYSA-N Iron Chemical compound [Fe] XEEYBQQBJWHFJM-UHFFFAOYSA-N 0.000 description 4
- 235000008708 Morus alba Nutrition 0.000 description 4
- 240000000249 Morus alba Species 0.000 description 4
- 235000009508 confectionery Nutrition 0.000 description 4
- 238000001816 cooling Methods 0.000 description 4
- 239000012530 fluid Substances 0.000 description 4
- 210000003205 muscle Anatomy 0.000 description 4
- 239000000126 substance Substances 0.000 description 4
- 208000002874 Acne Vulgaris Diseases 0.000 description 3
- 206010010774 Constipation Diseases 0.000 description 3
- 208000031226 Hyperlipidaemia Diseases 0.000 description 3
- 102000004877 Insulin Human genes 0.000 description 3
- 108090001061 Insulin Proteins 0.000 description 3
- MUBZPKHOEPUJKR-UHFFFAOYSA-N Oxalic acid Chemical compound OC(=O)C(O)=O MUBZPKHOEPUJKR-UHFFFAOYSA-N 0.000 description 3
- OAICVXFJPJFONN-UHFFFAOYSA-N Phosphorus Chemical compound [P] OAICVXFJPJFONN-UHFFFAOYSA-N 0.000 description 3
- 206010000496 acne Diseases 0.000 description 3
- 235000013361 beverage Nutrition 0.000 description 3
- 210000000988 bone and bone Anatomy 0.000 description 3
- 210000004556 brain Anatomy 0.000 description 3
- 150000001720 carbohydrates Chemical class 0.000 description 3
- 235000014633 carbohydrates Nutrition 0.000 description 3
- KRKNYBCHXYNGOX-UHFFFAOYSA-N citric acid Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O KRKNYBCHXYNGOX-UHFFFAOYSA-N 0.000 description 3
- 235000013399 edible fruits Nutrition 0.000 description 3
- 201000001421 hyperglycemia Diseases 0.000 description 3
- 238000002347 injection Methods 0.000 description 3
- 239000007924 injection Substances 0.000 description 3
- 229940125396 insulin Drugs 0.000 description 3
- 210000003734 kidney Anatomy 0.000 description 3
- 238000004519 manufacturing process Methods 0.000 description 3
- 210000005036 nerve Anatomy 0.000 description 3
- 239000011574 phosphorus Substances 0.000 description 3
- 235000014347 soups Nutrition 0.000 description 3
- 235000019605 sweet taste sensations Nutrition 0.000 description 3
- 230000008961 swelling Effects 0.000 description 3
- 230000035922 thirst Effects 0.000 description 3
- 108700012359 toxins Proteins 0.000 description 3
- 241000213006 Angelica dahurica Species 0.000 description 2
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 description 2
- 241000894006 Bacteria Species 0.000 description 2
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 description 2
- 244000201986 Cassia tora Species 0.000 description 2
- 235000014552 Cassia tora Nutrition 0.000 description 2
- 206010010726 Conjunctival oedema Diseases 0.000 description 2
- 206010012735 Diarrhoea Diseases 0.000 description 2
- 206010013774 Dry eye Diseases 0.000 description 2
- 208000000059 Dyspnea Diseases 0.000 description 2
- 206010013975 Dyspnoeas Diseases 0.000 description 2
- 235000006200 Glycyrrhiza glabra Nutrition 0.000 description 2
- 244000303040 Glycyrrhiza glabra Species 0.000 description 2
- 241001646826 Isodon rubescens Species 0.000 description 2
- BTJXBZZBBNNTOV-UHFFFAOYSA-N Linalyl benzoate Chemical compound CC(C)=CCCC(C)(C=C)OC(=O)C1=CC=CC=C1 BTJXBZZBBNNTOV-UHFFFAOYSA-N 0.000 description 2
- 102000010909 Monoamine Oxidase Human genes 0.000 description 2
- 108010062431 Monoamine oxidase Proteins 0.000 description 2
- 244000183278 Nephelium litchi Species 0.000 description 2
- PXHVJJICTQNCMI-UHFFFAOYSA-N Nickel Chemical compound [Ni] PXHVJJICTQNCMI-UHFFFAOYSA-N 0.000 description 2
- 241000283973 Oryctolagus cuniculus Species 0.000 description 2
- 206010039966 Senile dementia Diseases 0.000 description 2
- 229930006000 Sucrose Natural products 0.000 description 2
- CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 description 2
- GAMYVSCDDLXAQW-AOIWZFSPSA-N Thermopsosid Natural products O(C)c1c(O)ccc(C=2Oc3c(c(O)cc(O[C@H]4[C@H](O)[C@@H](O)[C@H](O)[C@H](CO)O4)c3)C(=O)C=2)c1 GAMYVSCDDLXAQW-AOIWZFSPSA-N 0.000 description 2
- 229930013930 alkaloid Natural products 0.000 description 2
- 150000003797 alkaloid derivatives Chemical class 0.000 description 2
- 230000000844 anti-bacterial effect Effects 0.000 description 2
- 230000009286 beneficial effect Effects 0.000 description 2
- 230000008901 benefit Effects 0.000 description 2
- 229910052791 calcium Inorganic materials 0.000 description 2
- 239000011575 calcium Substances 0.000 description 2
- 210000000038 chest Anatomy 0.000 description 2
- 208000001848 dysentery Diseases 0.000 description 2
- 230000002708 enhancing effect Effects 0.000 description 2
- 230000001815 facial effect Effects 0.000 description 2
- 229930003944 flavone Natural products 0.000 description 2
- 150000002212 flavone derivatives Chemical class 0.000 description 2
- 235000011949 flavones Nutrition 0.000 description 2
- -1 flavonoid compound Chemical class 0.000 description 2
- 239000000796 flavoring agent Substances 0.000 description 2
- 235000019634 flavors Nutrition 0.000 description 2
- 208000018997 giddiness Diseases 0.000 description 2
- 150000004676 glycans Chemical class 0.000 description 2
- 229930182470 glycoside Natural products 0.000 description 2
- 150000002338 glycosides Chemical class 0.000 description 2
- 230000036039 immunity Effects 0.000 description 2
- 230000001976 improved effect Effects 0.000 description 2
- 230000004377 improving vision Effects 0.000 description 2
- 210000000936 intestine Anatomy 0.000 description 2
- 229910052742 iron Inorganic materials 0.000 description 2
- 210000002429 large intestine Anatomy 0.000 description 2
- 239000002398 materia medica Substances 0.000 description 2
- 230000006996 mental state Effects 0.000 description 2
- 230000004060 metabolic process Effects 0.000 description 2
- 201000009240 nasopharyngitis Diseases 0.000 description 2
- 230000035764 nutrition Effects 0.000 description 2
- 235000016709 nutrition Nutrition 0.000 description 2
- 238000004806 packaging method and process Methods 0.000 description 2
- 230000000144 pharmacologic effect Effects 0.000 description 2
- 229920001282 polysaccharide Polymers 0.000 description 2
- 239000005017 polysaccharide Substances 0.000 description 2
- 229910052700 potassium Inorganic materials 0.000 description 2
- 239000000047 product Substances 0.000 description 2
- 230000029058 respiratory gaseous exchange Effects 0.000 description 2
- 230000033764 rhythmic process Effects 0.000 description 2
- 230000003860 sleep quality Effects 0.000 description 2
- 238000005728 strengthening Methods 0.000 description 2
- QMGVPVSNSZLJIA-FVWCLLPLSA-N strychnine Chemical compound O([C@H]1CC(N([C@H]2[C@H]1[C@H]1C3)C=4C5=CC=CC=4)=O)CC=C1CN1[C@@H]3[C@]25CC1 QMGVPVSNSZLJIA-FVWCLLPLSA-N 0.000 description 2
- 239000005720 sucrose Substances 0.000 description 2
- 208000011580 syndromic disease Diseases 0.000 description 2
- 238000002560 therapeutic procedure Methods 0.000 description 2
- 239000011573 trace mineral Substances 0.000 description 2
- 235000013619 trace mineral Nutrition 0.000 description 2
- 230000002936 tranquilizing effect Effects 0.000 description 2
- 235000010374 vitamin B1 Nutrition 0.000 description 2
- 239000011691 vitamin B1 Substances 0.000 description 2
- 235000019154 vitamin C Nutrition 0.000 description 2
- 239000011718 vitamin C Substances 0.000 description 2
- VHBFFQKBGNRLFZ-UHFFFAOYSA-N vitamin p Natural products O1C2=CC=CC=C2C(=O)C=C1C1=CC=CC=C1 VHBFFQKBGNRLFZ-UHFFFAOYSA-N 0.000 description 2
- BJEPYKJPYRNKOW-REOHCLBHSA-N (S)-malic acid Chemical compound OC(=O)[C@@H](O)CC(O)=O BJEPYKJPYRNKOW-REOHCLBHSA-N 0.000 description 1
- 208000004998 Abdominal Pain Diseases 0.000 description 1
- 244000291564 Allium cepa Species 0.000 description 1
- 208000024827 Alzheimer disease Diseases 0.000 description 1
- 208000000044 Amnesia Diseases 0.000 description 1
- 208000031091 Amnestic disease Diseases 0.000 description 1
- 206010002091 Anaesthesia Diseases 0.000 description 1
- 208000019901 Anxiety disease Diseases 0.000 description 1
- 241000205585 Aquilegia canadensis Species 0.000 description 1
- 206010003210 Arteriosclerosis Diseases 0.000 description 1
- 208000006820 Arthralgia Diseases 0.000 description 1
- 206010003445 Ascites Diseases 0.000 description 1
- 241000208838 Asteraceae Species 0.000 description 1
- 208000035985 Body Odor Diseases 0.000 description 1
- 206010006298 Breast pain Diseases 0.000 description 1
- 206010055000 Bromhidrosis Diseases 0.000 description 1
- 241000282472 Canis lupus familiaris Species 0.000 description 1
- 206010007247 Carbuncle Diseases 0.000 description 1
- 235000009604 Chrysanthemum X morifolium Nutrition 0.000 description 1
- 235000005979 Citrus limon Nutrition 0.000 description 1
- 244000131522 Citrus pyriformis Species 0.000 description 1
- RYGMFSIKBFXOCR-UHFFFAOYSA-N Copper Chemical compound [Cu] RYGMFSIKBFXOCR-UHFFFAOYSA-N 0.000 description 1
- 206010011224 Cough Diseases 0.000 description 1
- 229920000832 Cutin Polymers 0.000 description 1
- 206010011703 Cyanosis Diseases 0.000 description 1
- IVOMOUWHDPKRLL-KQYNXXCUSA-N Cyclic adenosine monophosphate Chemical compound C([C@H]1O2)OP(O)(=O)O[C@H]1[C@@H](O)[C@@H]2N1C(N=CN=C2N)=C2N=C1 IVOMOUWHDPKRLL-KQYNXXCUSA-N 0.000 description 1
- ZZZCUOFIHGPKAK-UHFFFAOYSA-N D-erythro-ascorbic acid Natural products OCC1OC(=O)C(O)=C1O ZZZCUOFIHGPKAK-UHFFFAOYSA-N 0.000 description 1
- FEWJPZIEWOKRBE-JCYAYHJZSA-N Dextrotartaric acid Chemical compound OC(=O)[C@H](O)[C@@H](O)C(O)=O FEWJPZIEWOKRBE-JCYAYHJZSA-N 0.000 description 1
- 235000000525 Dimocarpus longan Nutrition 0.000 description 1
- 208000003556 Dry Eye Syndromes Diseases 0.000 description 1
- 108090000790 Enzymes Proteins 0.000 description 1
- 102000004190 Enzymes Human genes 0.000 description 1
- 235000009008 Eriobotrya japonica Nutrition 0.000 description 1
- 244000061508 Eriobotrya japonica Species 0.000 description 1
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 1
- 244000268590 Euryale ferox Species 0.000 description 1
- 235000006487 Euryale ferox Nutrition 0.000 description 1
- 208000004930 Fatty Liver Diseases 0.000 description 1
- 108010057573 Flavoproteins Proteins 0.000 description 1
- 102000003983 Flavoproteins Human genes 0.000 description 1
- 206010060891 General symptom Diseases 0.000 description 1
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 1
- WHUUTDBJXJRKMK-UHFFFAOYSA-N Glutamic acid Natural products OC(=O)C(N)CCC(O)=O WHUUTDBJXJRKMK-UHFFFAOYSA-N 0.000 description 1
- 240000008669 Hedera helix Species 0.000 description 1
- 235000017443 Hedysarum boreale Nutrition 0.000 description 1
- 235000007858 Hedysarum occidentale Nutrition 0.000 description 1
- 102000001554 Hemoglobins Human genes 0.000 description 1
- 108010054147 Hemoglobins Proteins 0.000 description 1
- 206010019708 Hepatic steatosis Diseases 0.000 description 1
- 208000006083 Hypokinesia Diseases 0.000 description 1
- 229920001202 Inulin Polymers 0.000 description 1
- ONIBWKKTOPOVIA-BYPYZUCNSA-N L-Proline Chemical compound OC(=O)[C@@H]1CCCN1 ONIBWKKTOPOVIA-BYPYZUCNSA-N 0.000 description 1
- QNAYBMKLOCPYGJ-REOHCLBHSA-N L-alanine Chemical compound C[C@H](N)C(O)=O QNAYBMKLOCPYGJ-REOHCLBHSA-N 0.000 description 1
- CKLJMWTZIZZHCS-REOHCLBHSA-N L-aspartic acid Chemical compound OC(=O)[C@@H](N)CC(O)=O CKLJMWTZIZZHCS-REOHCLBHSA-N 0.000 description 1
- WHUUTDBJXJRKMK-VKHMYHEASA-N L-glutamic acid Chemical compound OC(=O)[C@@H](N)CCC(O)=O WHUUTDBJXJRKMK-VKHMYHEASA-N 0.000 description 1
- ROHFNLRQFUQHCH-YFKPBYRVSA-N L-leucine Chemical compound CC(C)C[C@H](N)C(O)=O ROHFNLRQFUQHCH-YFKPBYRVSA-N 0.000 description 1
- KZSNJWFQEVHDMF-BYPYZUCNSA-N L-valine Chemical compound CC(C)[C@H](N)C(O)=O KZSNJWFQEVHDMF-BYPYZUCNSA-N 0.000 description 1
- 206010023644 Lacrimation increased Diseases 0.000 description 1
- ROHFNLRQFUQHCH-UHFFFAOYSA-N Leucine Natural products CC(C)CC(N)C(O)=O ROHFNLRQFUQHCH-UHFFFAOYSA-N 0.000 description 1
- 241001071917 Lithospermum Species 0.000 description 1
- 241001465754 Metazoa Species 0.000 description 1
- 241000699670 Mus sp. Species 0.000 description 1
- 102000007999 Nuclear Proteins Human genes 0.000 description 1
- 108010089610 Nuclear Proteins Proteins 0.000 description 1
- QMGVPVSNSZLJIA-UHFFFAOYSA-N Nux Vomica Natural products C1C2C3C4N(C=5C6=CC=CC=5)C(=O)CC3OCC=C2CN2C1C46CC2 QMGVPVSNSZLJIA-UHFFFAOYSA-N 0.000 description 1
- 206010030113 Oedema Diseases 0.000 description 1
- 235000012920 Oroxylum indicum Nutrition 0.000 description 1
- 240000005790 Oroxylum indicum Species 0.000 description 1
- 235000005035 Panax pseudoginseng ssp. pseudoginseng Nutrition 0.000 description 1
- 235000003140 Panax quinquefolius Nutrition 0.000 description 1
- 240000005373 Panax quinquefolius Species 0.000 description 1
- 102000035195 Peptidases Human genes 0.000 description 1
- 108091005804 Peptidases Proteins 0.000 description 1
- 206010034960 Photophobia Diseases 0.000 description 1
- 208000004880 Polyuria Diseases 0.000 description 1
- 241001619461 Poria <basidiomycete fungus> Species 0.000 description 1
- 235000008599 Poria cocos Nutrition 0.000 description 1
- 244000197580 Poria cocos Species 0.000 description 1
- ZLMJMSJWJFRBEC-UHFFFAOYSA-N Potassium Chemical compound [K] ZLMJMSJWJFRBEC-UHFFFAOYSA-N 0.000 description 1
- ONIBWKKTOPOVIA-UHFFFAOYSA-N Proline Natural products OC(=O)C1CCCN1 ONIBWKKTOPOVIA-UHFFFAOYSA-N 0.000 description 1
- 206010057071 Rectal tenesmus Diseases 0.000 description 1
- 241000405414 Rehmannia Species 0.000 description 1
- 241001093760 Sapindaceae Species 0.000 description 1
- 206010040943 Skin Ulcer Diseases 0.000 description 1
- 208000010340 Sleep Deprivation Diseases 0.000 description 1
- 208000013738 Sleep Initiation and Maintenance disease Diseases 0.000 description 1
- 229920002472 Starch Polymers 0.000 description 1
- UEDUENGHJMELGK-HYDKPPNVSA-N Stevioside Chemical compound O([C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1O[C@]12C(=C)C[C@@]3(C1)CC[C@@H]1[C@@](C)(CCC[C@]1([C@@H]3CC2)C)C(=O)O[C@H]1[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O1)O)[C@@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O UEDUENGHJMELGK-HYDKPPNVSA-N 0.000 description 1
- 241001279009 Strychnos toxifera Species 0.000 description 1
- 208000033809 Suppuration Diseases 0.000 description 1
- 241000779819 Syncarpia glomulifera Species 0.000 description 1
- FEWJPZIEWOKRBE-UHFFFAOYSA-N Tartaric acid Natural products [H+].[H+].[O-]C(=O)C(O)C(O)C([O-])=O FEWJPZIEWOKRBE-UHFFFAOYSA-N 0.000 description 1
- 235000011171 Thladiantha grosvenorii Nutrition 0.000 description 1
- 244000185386 Thladiantha grosvenorii Species 0.000 description 1
- 208000009205 Tinnitus Diseases 0.000 description 1
- 240000001085 Trapa natans Species 0.000 description 1
- 208000025865 Ulcer Diseases 0.000 description 1
- KZSNJWFQEVHDMF-UHFFFAOYSA-N Valine Natural products CC(C)C(N)C(O)=O KZSNJWFQEVHDMF-UHFFFAOYSA-N 0.000 description 1
- 208000012886 Vertigo Diseases 0.000 description 1
- 241000700605 Viruses Species 0.000 description 1
- 206010047513 Vision blurred Diseases 0.000 description 1
- 229930003268 Vitamin C Natural products 0.000 description 1
- 208000027418 Wounds and injury Diseases 0.000 description 1
- HCHKCACWOHOZIP-UHFFFAOYSA-N Zinc Chemical compound [Zn] HCHKCACWOHOZIP-UHFFFAOYSA-N 0.000 description 1
- 235000006886 Zingiber officinale Nutrition 0.000 description 1
- 244000273928 Zingiber officinale Species 0.000 description 1
- 210000001015 abdomen Anatomy 0.000 description 1
- 206010000269 abscess Diseases 0.000 description 1
- 238000010521 absorption reaction Methods 0.000 description 1
- 230000001133 acceleration Effects 0.000 description 1
- 238000009825 accumulation Methods 0.000 description 1
- 239000002253 acid Substances 0.000 description 1
- 150000007513 acids Chemical class 0.000 description 1
- 230000003213 activating effect Effects 0.000 description 1
- 239000013543 active substance Substances 0.000 description 1
- 201000001028 acute contagious conjunctivitis Diseases 0.000 description 1
- 235000004279 alanine Nutrition 0.000 description 1
- OENHQHLEOONYIE-UKMVMLAPSA-N all-trans beta-carotene Natural products CC=1CCCC(C)(C)C=1/C=C/C(/C)=C/C=C/C(/C)=C/C=C/C=C(C)C=CC=C(C)C=CC1=C(C)CCCC1(C)C OENHQHLEOONYIE-UKMVMLAPSA-N 0.000 description 1
- BJEPYKJPYRNKOW-UHFFFAOYSA-N alpha-hydroxysuccinic acid Natural products OC(=O)C(O)CC(O)=O BJEPYKJPYRNKOW-UHFFFAOYSA-N 0.000 description 1
- 235000001014 amino acid Nutrition 0.000 description 1
- 150000001413 amino acids Chemical class 0.000 description 1
- 230000006986 amnesia Effects 0.000 description 1
- 230000037005 anaesthesia Effects 0.000 description 1
- 230000008485 antagonism Effects 0.000 description 1
- PYKYMHQGRFAEBM-UHFFFAOYSA-N anthraquinone Natural products CCC(=O)c1c(O)c2C(=O)C3C(C=CC=C3O)C(=O)c2cc1CC(=O)OC PYKYMHQGRFAEBM-UHFFFAOYSA-N 0.000 description 1
- 150000004056 anthraquinones Chemical class 0.000 description 1
- 230000003712 anti-aging effect Effects 0.000 description 1
- 230000000843 anti-fungal effect Effects 0.000 description 1
- 230000003110 anti-inflammatory effect Effects 0.000 description 1
- 230000000702 anti-platelet effect Effects 0.000 description 1
- 239000003146 anticoagulant agent Substances 0.000 description 1
- 229940121375 antifungal agent Drugs 0.000 description 1
- 230000036506 anxiety Effects 0.000 description 1
- 230000036528 appetite Effects 0.000 description 1
- 235000019789 appetite Nutrition 0.000 description 1
- 208000011775 arteriosclerosis disease Diseases 0.000 description 1
- 235000003704 aspartic acid Nutrition 0.000 description 1
- 208000003464 asthenopia Diseases 0.000 description 1
- 230000003796 beauty Effects 0.000 description 1
- WQZGKKKJIJFFOK-VFUOTHLCSA-N beta-D-glucose Chemical compound OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-VFUOTHLCSA-N 0.000 description 1
- OQFSQFPPLPISGP-UHFFFAOYSA-N beta-carboxyaspartic acid Natural products OC(=O)C(N)C(C(O)=O)C(O)=O OQFSQFPPLPISGP-UHFFFAOYSA-N 0.000 description 1
- 235000013734 beta-carotene Nutrition 0.000 description 1
- 239000011648 beta-carotene Substances 0.000 description 1
- TUPZEYHYWIEDIH-WAIFQNFQSA-N beta-carotene Natural products CC(=C/C=C/C=C(C)/C=C/C=C(C)/C=C/C1=C(C)CCCC1(C)C)C=CC=C(/C)C=CC2=CCCCC2(C)C TUPZEYHYWIEDIH-WAIFQNFQSA-N 0.000 description 1
- 229960002747 betacarotene Drugs 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- 235000019658 bitter taste Nutrition 0.000 description 1
- 230000000740 bleeding effect Effects 0.000 description 1
- 230000017531 blood circulation Effects 0.000 description 1
- 230000023555 blood coagulation Effects 0.000 description 1
- 238000009835 boiling Methods 0.000 description 1
- 210000004958 brain cell Anatomy 0.000 description 1
- 235000020341 brewed tea Nutrition 0.000 description 1
- 230000003177 cardiotonic effect Effects 0.000 description 1
- 210000004027 cell Anatomy 0.000 description 1
- 239000003610 charcoal Substances 0.000 description 1
- 239000003795 chemical substances by application Substances 0.000 description 1
- 230000001684 chronic effect Effects 0.000 description 1
- 230000004087 circulation Effects 0.000 description 1
- 208000019425 cirrhosis of liver Diseases 0.000 description 1
- 235000015165 citric acid Nutrition 0.000 description 1
- 150000001875 compounds Chemical class 0.000 description 1
- 238000010411 cooking Methods 0.000 description 1
- 229910052802 copper Inorganic materials 0.000 description 1
- 239000010949 copper Substances 0.000 description 1
- 239000006071 cream Substances 0.000 description 1
- 230000006378 damage Effects 0.000 description 1
- 230000000378 dietary effect Effects 0.000 description 1
- 235000014113 dietary fatty acids Nutrition 0.000 description 1
- 230000029087 digestion Effects 0.000 description 1
- 208000035475 disorder Diseases 0.000 description 1
- 230000035619 diuresis Effects 0.000 description 1
- 230000008030 elimination Effects 0.000 description 1
- 238000003379 elimination reaction Methods 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 238000003912 environmental pollution Methods 0.000 description 1
- 230000003203 everyday effect Effects 0.000 description 1
- 210000003414 extremity Anatomy 0.000 description 1
- 208000030533 eye disease Diseases 0.000 description 1
- 238000005562 fading Methods 0.000 description 1
- 229930195729 fatty acid Natural products 0.000 description 1
- 239000000194 fatty acid Substances 0.000 description 1
- 150000004665 fatty acids Chemical class 0.000 description 1
- 208000010706 fatty liver disease Diseases 0.000 description 1
- 230000002349 favourable effect Effects 0.000 description 1
- 229930003935 flavonoid Natural products 0.000 description 1
- 235000017173 flavonoids Nutrition 0.000 description 1
- 244000230030 foxtail bristlegrass Species 0.000 description 1
- 230000002496 gastric effect Effects 0.000 description 1
- 235000008397 ginger Nutrition 0.000 description 1
- 235000008434 ginseng Nutrition 0.000 description 1
- 206010018388 glossodynia Diseases 0.000 description 1
- 239000008103 glucose Substances 0.000 description 1
- 235000013922 glutamic acid Nutrition 0.000 description 1
- 239000004220 glutamic acid Substances 0.000 description 1
- 239000001947 glycyrrhiza glabra rhizome/root Substances 0.000 description 1
- LPLVUJXQOOQHMX-QWBHMCJMSA-N glycyrrhizinic acid Chemical compound O([C@@H]1[C@@H](O)[C@H](O)[C@H](O[C@@H]1O[C@@H]1C([C@H]2[C@]([C@@H]3[C@@]([C@@]4(CC[C@@]5(C)CC[C@@](C)(C[C@H]5C4=CC3=O)C(O)=O)C)(C)CC2)(C)CC1)(C)C)C(O)=O)[C@@H]1O[C@H](C(O)=O)[C@@H](O)[C@H](O)[C@H]1O LPLVUJXQOOQHMX-QWBHMCJMSA-N 0.000 description 1
- 230000036449 good health Effects 0.000 description 1
- 238000009499 grossing Methods 0.000 description 1
- 230000002650 habitual effect Effects 0.000 description 1
- 238000003306 harvesting Methods 0.000 description 1
- 235000013402 health food Nutrition 0.000 description 1
- 208000006454 hepatitis Diseases 0.000 description 1
- 231100000283 hepatitis Toxicity 0.000 description 1
- 208000013403 hyperactivity Diseases 0.000 description 1
- 230000001631 hypertensive effect Effects 0.000 description 1
- 230000001939 inductive effect Effects 0.000 description 1
- 208000014674 injury Diseases 0.000 description 1
- 229910052500 inorganic mineral Inorganic materials 0.000 description 1
- 206010022437 insomnia Diseases 0.000 description 1
- 229940029339 inulin Drugs 0.000 description 1
- JYJIGFIDKWBXDU-MNNPPOADSA-N inulin Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)OC[C@]1(OC[C@]2(OC[C@]3(OC[C@]4(OC[C@]5(OC[C@]6(OC[C@]7(OC[C@]8(OC[C@]9(OC[C@]%10(OC[C@]%11(OC[C@]%12(OC[C@]%13(OC[C@]%14(OC[C@]%15(OC[C@]%16(OC[C@]%17(OC[C@]%18(OC[C@]%19(OC[C@]%20(OC[C@]%21(OC[C@]%22(OC[C@]%23(OC[C@]%24(OC[C@]%25(OC[C@]%26(OC[C@]%27(OC[C@]%28(OC[C@]%29(OC[C@]%30(OC[C@]%31(OC[C@]%32(OC[C@]%33(OC[C@]%34(OC[C@]%35(OC[C@]%36(O[C@@H]%37[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O%37)O)[C@H]([C@H](O)[C@@H](CO)O%36)O)[C@H]([C@H](O)[C@@H](CO)O%35)O)[C@H]([C@H](O)[C@@H](CO)O%34)O)[C@H]([C@H](O)[C@@H](CO)O%33)O)[C@H]([C@H](O)[C@@H](CO)O%32)O)[C@H]([C@H](O)[C@@H](CO)O%31)O)[C@H]([C@H](O)[C@@H](CO)O%30)O)[C@H]([C@H](O)[C@@H](CO)O%29)O)[C@H]([C@H](O)[C@@H](CO)O%28)O)[C@H]([C@H](O)[C@@H](CO)O%27)O)[C@H]([C@H](O)[C@@H](CO)O%26)O)[C@H]([C@H](O)[C@@H](CO)O%25)O)[C@H]([C@H](O)[C@@H](CO)O%24)O)[C@H]([C@H](O)[C@@H](CO)O%23)O)[C@H]([C@H](O)[C@@H](CO)O%22)O)[C@H]([C@H](O)[C@@H](CO)O%21)O)[C@H]([C@H](O)[C@@H](CO)O%20)O)[C@H]([C@H](O)[C@@H](CO)O%19)O)[C@H]([C@H](O)[C@@H](CO)O%18)O)[C@H]([C@H](O)[C@@H](CO)O%17)O)[C@H]([C@H](O)[C@@H](CO)O%16)O)[C@H]([C@H](O)[C@@H](CO)O%15)O)[C@H]([C@H](O)[C@@H](CO)O%14)O)[C@H]([C@H](O)[C@@H](CO)O%13)O)[C@H]([C@H](O)[C@@H](CO)O%12)O)[C@H]([C@H](O)[C@@H](CO)O%11)O)[C@H]([C@H](O)[C@@H](CO)O%10)O)[C@H]([C@H](O)[C@@H](CO)O9)O)[C@H]([C@H](O)[C@@H](CO)O8)O)[C@H]([C@H](O)[C@@H](CO)O7)O)[C@H]([C@H](O)[C@@H](CO)O6)O)[C@H]([C@H](O)[C@@H](CO)O5)O)[C@H]([C@H](O)[C@@H](CO)O4)O)[C@H]([C@H](O)[C@@H](CO)O3)O)[C@H]([C@H](O)[C@@H](CO)O2)O)[C@@H](O)[C@H](O)[C@@H](CO)O1 JYJIGFIDKWBXDU-MNNPPOADSA-N 0.000 description 1
- 210000003127 knee Anatomy 0.000 description 1
- 230000004317 lacrimation Effects 0.000 description 1
- 150000002596 lactones Chemical class 0.000 description 1
- 230000002475 laxative effect Effects 0.000 description 1
- 235000005772 leucine Nutrition 0.000 description 1
- 206010024378 leukocytosis Diseases 0.000 description 1
- 235000011477 liquorice Nutrition 0.000 description 1
- 230000007774 longterm Effects 0.000 description 1
- 238000012423 maintenance Methods 0.000 description 1
- 239000001630 malic acid Substances 0.000 description 1
- 235000011090 malic acid Nutrition 0.000 description 1
- WPBNNNQJVZRUHP-UHFFFAOYSA-L manganese(2+);methyl n-[[2-(methoxycarbonylcarbamothioylamino)phenyl]carbamothioyl]carbamate;n-[2-(sulfidocarbothioylamino)ethyl]carbamodithioate Chemical compound [Mn+2].[S-]C(=S)NCCNC([S-])=S.COC(=O)NC(=S)NC1=CC=CC=C1NC(=S)NC(=O)OC WPBNNNQJVZRUHP-UHFFFAOYSA-L 0.000 description 1
- 235000013372 meat Nutrition 0.000 description 1
- 230000007246 mechanism Effects 0.000 description 1
- 230000007087 memory ability Effects 0.000 description 1
- 230000002175 menstrual effect Effects 0.000 description 1
- 230000003340 mental effect Effects 0.000 description 1
- 230000004630 mental health Effects 0.000 description 1
- 230000002503 metabolic effect Effects 0.000 description 1
- 230000007102 metabolic function Effects 0.000 description 1
- 238000000034 method Methods 0.000 description 1
- 239000011707 mineral Substances 0.000 description 1
- 235000010755 mineral Nutrition 0.000 description 1
- 208000018962 mouth sore Diseases 0.000 description 1
- 210000003097 mucus Anatomy 0.000 description 1
- 229910052759 nickel Inorganic materials 0.000 description 1
- QJGQUHMNIGDVPM-UHFFFAOYSA-N nitrogen group Chemical group [N] QJGQUHMNIGDVPM-UHFFFAOYSA-N 0.000 description 1
- 231100000862 numbness Toxicity 0.000 description 1
- 230000000050 nutritive effect Effects 0.000 description 1
- 235000006408 oxalic acid Nutrition 0.000 description 1
- 230000003647 oxidation Effects 0.000 description 1
- 238000007254 oxidation reaction Methods 0.000 description 1
- 244000052769 pathogen Species 0.000 description 1
- 230000001717 pathogenic effect Effects 0.000 description 1
- 210000005259 peripheral blood Anatomy 0.000 description 1
- 239000011886 peripheral blood Substances 0.000 description 1
- WVDDGKGOMKODPV-ZQBYOMGUSA-N phenyl(114C)methanol Chemical class O[14CH2]C1=CC=CC=C1 WVDDGKGOMKODPV-ZQBYOMGUSA-N 0.000 description 1
- 230000001766 physiological effect Effects 0.000 description 1
- 239000000049 pigment Substances 0.000 description 1
- 239000001739 pinus spp. Substances 0.000 description 1
- 231100000614 poison Toxicity 0.000 description 1
- 235000013824 polyphenols Nutrition 0.000 description 1
- 239000011591 potassium Substances 0.000 description 1
- 235000013324 preserved food Nutrition 0.000 description 1
- 235000013930 proline Nutrition 0.000 description 1
- 230000002035 prolonged effect Effects 0.000 description 1
- 238000010791 quenching Methods 0.000 description 1
- 230000000171 quenching effect Effects 0.000 description 1
- 239000001397 quillaja saponaria molina bark Substances 0.000 description 1
- 239000000941 radioactive substance Substances 0.000 description 1
- 230000008929 regeneration Effects 0.000 description 1
- 238000011069 regeneration method Methods 0.000 description 1
- 230000001105 regulatory effect Effects 0.000 description 1
- 239000011347 resin Substances 0.000 description 1
- 229920005989 resin Polymers 0.000 description 1
- 235000009165 saligot Nutrition 0.000 description 1
- 239000004576 sand Substances 0.000 description 1
- 229930182490 saponin Natural products 0.000 description 1
- 150000007949 saponins Chemical class 0.000 description 1
- 235000015067 sauces Nutrition 0.000 description 1
- 230000028327 secretion Effects 0.000 description 1
- 208000013220 shortness of breath Diseases 0.000 description 1
- 230000036558 skin tension Effects 0.000 description 1
- 231100000019 skin ulcer Toxicity 0.000 description 1
- 230000007958 sleep Effects 0.000 description 1
- 230000000391 smoking effect Effects 0.000 description 1
- 208000010110 spontaneous platelet aggregation Diseases 0.000 description 1
- 235000019698 starch Nutrition 0.000 description 1
- 239000008107 starch Substances 0.000 description 1
- 231100000240 steatosis hepatitis Toxicity 0.000 description 1
- 229940013618 stevioside Drugs 0.000 description 1
- OHHNJQXIOPOJSC-UHFFFAOYSA-N stevioside Natural products CC1(CCCC2(C)C3(C)CCC4(CC3(CCC12C)CC4=C)OC5OC(CO)C(O)C(O)C5OC6OC(CO)C(O)C(O)C6O)C(=O)OC7OC(CO)C(O)C(O)C7O OHHNJQXIOPOJSC-UHFFFAOYSA-N 0.000 description 1
- 235000019202 steviosides Nutrition 0.000 description 1
- 230000004936 stimulating effect Effects 0.000 description 1
- 238000003756 stirring Methods 0.000 description 1
- 229960005453 strychnine Drugs 0.000 description 1
- 239000013589 supplement Substances 0.000 description 1
- 230000001502 supplementing effect Effects 0.000 description 1
- 230000008093 supporting effect Effects 0.000 description 1
- 230000002195 synergetic effect Effects 0.000 description 1
- 239000011975 tartaric acid Substances 0.000 description 1
- 235000002906 tartaric acid Nutrition 0.000 description 1
- 235000019640 taste Nutrition 0.000 description 1
- 208000012271 tenesmus Diseases 0.000 description 1
- 231100000886 tinnitus Toxicity 0.000 description 1
- 231100000331 toxic Toxicity 0.000 description 1
- 230000002588 toxic effect Effects 0.000 description 1
- 239000003440 toxic substance Substances 0.000 description 1
- HFFLGKNGCAIQMO-UHFFFAOYSA-N trichloroacetaldehyde Chemical compound ClC(Cl)(Cl)C=O HFFLGKNGCAIQMO-UHFFFAOYSA-N 0.000 description 1
- 150000003648 triterpenes Chemical class 0.000 description 1
- 150000008130 triterpenoid saponins Chemical class 0.000 description 1
- 229940036248 turpentine Drugs 0.000 description 1
- 231100000397 ulcer Toxicity 0.000 description 1
- 239000004474 valine Substances 0.000 description 1
- 235000014393 valine Nutrition 0.000 description 1
- 231100000889 vertigo Toxicity 0.000 description 1
- 235000019155 vitamin A Nutrition 0.000 description 1
- 239000011719 vitamin A Substances 0.000 description 1
- 235000019156 vitamin B Nutrition 0.000 description 1
- 239000011720 vitamin B Substances 0.000 description 1
- 235000019164 vitamin B2 Nutrition 0.000 description 1
- 239000011716 vitamin B2 Substances 0.000 description 1
- 235000019158 vitamin B6 Nutrition 0.000 description 1
- 239000011726 vitamin B6 Substances 0.000 description 1
- 238000005406 washing Methods 0.000 description 1
- 229940126673 western medicines Drugs 0.000 description 1
- 239000011701 zinc Substances 0.000 description 1
- 229910052725 zinc Inorganic materials 0.000 description 1
- OENHQHLEOONYIE-JLTXGRSLSA-N β-Carotene Chemical compound CC=1CCCC(C)(C)C=1\C=C\C(\C)=C\C=C\C(\C)=C\C=C\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C OENHQHLEOONYIE-JLTXGRSLSA-N 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23F—COFFEE; TEA; THEIR SUBSTITUTES; MANUFACTURE, PREPARATION, OR INFUSION THEREOF
- A23F3/00—Tea; Tea substitutes; Preparations thereof
- A23F3/34—Tea substitutes, e.g. matè; Extracts or infusions thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/28—Asteraceae or Compositae (Aster or Sunflower family), e.g. chamomile, feverfew, yarrow or echinacea
- A61K36/287—Chrysanthemum, e.g. daisy
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/34—Campanulaceae (Bellflower family)
- A61K36/344—Codonopsis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/48—Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
- A61K36/482—Cassia, e.g. golden shower tree
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/62—Nymphaeaceae (Water-lily family)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/77—Sapindaceae (Soapberry family), e.g. lychee or soapberry
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/14—Prodigestives, e.g. acids, enzymes, appetite stimulants, antidyspeptics, tonics, antiflatulents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/04—Drugs for disorders of the respiratory system for throat disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/10—Anti-acne agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/20—Hypnotics; Sedatives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/06—Antihyperlipidemics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P39/00—General protective or antinoxious agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P39/00—General protective or antinoxious agents
- A61P39/02—Antidotes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P39/00—General protective or antinoxious agents
- A61P39/06—Free radical scavengers or antioxidants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/06—Antianaemics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives
Abstract
本发明公开一种菊花六宝茶及其制备方法,该菊花六宝茶是由以下重量份的原料制成的:菊花8~18份、荷叶4~8份、莲子8~12份、龙眼肉4~9份、党参4~9份和决明子3~5份。制备过程为:(1)将莲子、荷叶、龙眼肉和决明子,洗净晒干,去除腐坏颗粒,分别各自粉碎过80‑120目筛;(2)将党参,洗净晒干,切段,粉碎过80‑120目筛;(3)将菊花,用砂锅小火焙干,粉碎过80‑120目筛;(4)将上述的菊花、荷叶、莲子、龙眼肉、党参和决明子的粉末,混合均匀,装入茶叶袋,即得菊花六宝茶。本菊花六堡茶具有排毒养颜、疏散风热,平抑肝阳,清肝明目,清热解毒,润肺、养胃、清肝、护肝、补虚劳和抗衰老之功效。
Description
技术领域
本发明涉及保健茶,特别涉及一种菊花六宝茶及其制备方法。
背景技术
茶叶源于中国,茶叶最早是被作为祭品使用的。但从春秋后期就被人们作为菜食,在西汉中期发展为药用,西汉后期才发展为宫廷高级饮料,普及民间作为普通饮料那是西晋以后的事。发现最早人工种植茶叶的遗迹在浙江余姚的田螺山遗址,已有6000多年的历史。饮茶始于中国。如今很多人有饮茶的习惯,经常喝茶能使人精神振奋,增强思维和记忆能力,消除疲劳,促进新陈代谢,帮助消化,延续衰老。
随着现代生活节奏的加快和饮食等方面的原因,环境污染、食品安全与工作压力及饮食不洁、吸烟、饮酒、噪音干扰、大气放射物质对人们健康构成最大危险。随之而来的是人们身体免疫力下降,对疾病抵抗能力减弱,容易生各种疾病,比如高血压、高血糖、高脂血症、动脉硬化、眼疾等多种疾病,另一方面这些各种外源性毒素通过不同途径进入人的机体、危害健康,而机体新陈代谢功能的紊乱,极其容易把代谢中产生的各种废物堆积停滞在代谢管道中,最终会造成机体的各种功能紊乱;这所造成的影响有如:面容憔悴和粗造;胸闷心慌;气血不足;耳鸣眼花;腰膝疼痛等。人们都想通过一些保健药物或茶类提高自身的免疫力,因为有市场需求,市场上涌现了许多的保健药物与保健茶,有的能起到一定疗效,有的并没能达到预期的疗效。
针对人体健康保养除了保证正确饮食、积极锻炼身体和自我调节心态以外,适当的饮用保健饮品也是其中的重要途径。而菊花保健茶,市场上也有一些报道或公开的专利文献,现经检索有关菊花茶的中国专利文献,列举一些如下:
1、中国专利,名称:一种菊花茶;申请专利号: 201811441243 .3;申请专利权人: 安徽金满盈农业科技有限公司;地址:河南省洛阳市涧西区西苑路48号;摘要:本发明公开了一种菊花茶,由下列重量份数 的原料制备而成:菊花5-9份、野生冬凌草4-8份、 紫草1-5份、木蝴蝶1-3份、麦冬1-3份、桑叶2-5 份、常青藤叶子3-6份、甘草1-4份、金银花2-6份、 茯苓3-5份,本发明还公开了上述菊花茶的制备 方法,具体步骤如下:将菊花、野生冬凌草、紫草、 木蝴蝶、麦冬、桑叶、常青藤叶子、甘草、金银花、 茯苓依次烘干打粉,然后混合在一起搅拌均匀 后,采用包装袋包装即可。本发明采用上述中药 成分制备得到的菊花茶在具备了普通菊花茶清 热解毒的功效的同时,也增加了其他的保健养生 功能,而且不具有任何毒副作用,适宜于广泛。
2、中国专利,名称:一种枸杞菊花茶;申请专利号: 201611209687.5;申请专利权人:谢彩红;地址:广东省惠州市博罗县杨村镇东平路16号;摘要:本发明公开了一种枸杞菊花茶,由以下组份 组成:枸杞子10克,菊花9朵,蜂蜜6克,水256克。 在菊花茶中加入枸杞,泡出来的茶就是有名的枸 杞菊花茶,能够疏风清热、解毒明目,并对胸闷、 心悸、气急、头晕、头痛、四肢麻木等有明显效果。因为两种都是护眼的药材,能有效缓解眼睛疲劳 或眼睛乾涩的症状,非常适合澈夜温习功课的学 生或电脑工作者饮用。
3、中国专利,名称:一种桑叶菊花茶;申请专利号: 201811448916 .8;申请专利权人: 江苏新岚实业有限公司;地址:江苏省徐州市睢宁县岚山镇 工业园区;摘要:本发明涉及保健茶技术领域,尤其是一种桑 叶菊花茶;其质量份组成如下:桑叶粉10-20份、 菊花20-30份、蜂蜜2-8份、甜菊糖3-5份、决明子 1 .2-2 .8份、枸杞2 .5-4份、柠檬3-4份、甘草节3-5 份、罗汉果3-5份、橘白2-4份、枇杷叶2-5份;本发 明的原料选用桑叶、菊花,组合使用使得各药物 的功效产生协同的作用,从而能够实现有效的疏 风、清热、清肝、明目的作用,同时还可以用于风 热感冒,头痛眩晕,目赤肿痛,眼目昏花,疮痈肿 毒,经过试验证实,本发明通过上述药物共同协 作后具有疏风、清热、清肝、明目的效果。
从检索到的文献我们可以了解到,目前市场上很多的菊花茶处方均具有一定的保健和治疗效果,但是如何将它们科学配伍,使之产生最大的功效,发挥出应有的效能,至今仍是中医中药研究的主攻方向。
发明内容
本发明的目的是提供一种配方区别于传统的菊花茶,具有排毒养颜、疏散风热,平抑肝阳,清肝明目,清热解毒,润肺、养胃、清肝、护肝、补虚劳和抗衰老之功效,使人提高生活质量,延年益寿的菊花六宝茶。
本发明是一种菊花六宝茶,该菊花六宝茶是由以下重量份的原料制成的:
菊花8~18份 荷叶4~8份 莲子8~12份
龙眼肉4~9份 党 参4~9份 决明子3~5份
所述的制备方法包括以下步骤:
(1)将莲子,荷叶,龙眼肉,决明子,洗净晒干,去除腐坏颗粒,分别各自粉碎过80-120目筛;
(2)将党参,洗净晒干,切段,粉碎过80-120目筛;
(3)将菊花,用砂锅小火焙干,粉碎过80-120目筛;
(4)将上述的菊花、荷叶、莲子、龙眼肉、党参和决明子的粉末,混合均匀,放入烤箱中,100-120℃烘烤0.5-1.5分钟,自然冷却后装入茶叶袋,即得菊花六宝茶。混合均匀后在烘烤,能将物料的有效成分烘烤渗出,泡茶时,有效成分能较好的融入到茶水中,且茶水味道更香。
本发明是一种菊花六宝茶其制备原料经现代科学分析,具有人体所需多种化学成分,如:
1、苯甲醇、脂类、菊花素、安息香酸芳樟醇酯、素馨内酯。
2、蛋白质、脂肪,维生素A、B、B1、B2、B6、C、D、K、P,磷、钙、铁、锌、铜、锰、镍等元素。
3、三萜皂苷、脂肪酸、黄酮类化合物、微量元素;芦素烷三萜类、谷氨酸、天冬氨酸、缬氨酸、丙氨酸、亮氨酸、脯氨酸、环磷酸腺苷。
4、酸类、含氮物、蛋白质、脂肪;维生素B1、B2、P、C。
5、皂甙、微量生物碱、蔗糖、菊糖、淀粉、粘液及树脂等。
8、黄酮、酚酮、蒽醌、内酯、多糖、氨基酸、微量元素。
上述菊花六宝茶其制备原料,可以从《中国药典》和其它中药手册中查到其别名、拉丁名以及产地、用法、为了了解本发明预防和抑止疾病的机理,现对上述各味原药的功效的药理性简述如下:
(1)菊花(拉丁学名:Dendranthema morifolium(Ramat. )Tzvel.):在植物分类学中是菊科、菊属的多年生宿根草本植物。菊花有着良好的保健和美容功效,可以用来饮食。性味甘、苦,微寒,归经归肺、肝经。【功能与主治】散风清热,平肝明目。用于风热感冒,头痛眩晕,目赤肿痛,眼目昏花等病症。【食疗作用】:1)、行气开部。菊花所含的挥发油性物质,具有行气止痛,解郁散结的作用,可缓解胸腹胀痛,下痢里急后重等病状,为止痛之食疗佳品。2)、抗菌消炎。菊花对多种细菌有抑制作用,内服外用,可治疗目赤,疮疡,皮肤溃烂等炎性病症。【文献选录】:《食物本草》:“主温脾胃,利胸隔。”《药性切用》:“功专辟秽治痢,虚人宜之。”《本草再新》:“解清座火,去寒积,治疮毒,消疽瘤。”《随息居饮食谱》:“和中下气,辟秽浊。治下痢腹痛。”《饮片新参》:“平肝解郁,理气止痛。”【保健食谱】:1)、薏米菊花雏鸽汤:【用料】:鸽子120克,菊花24朵,薏米 5克。【制作】:雏鸽杀好、收拾干净雏鸽剁小块,姜切片、葱切段鸽肉放入沙煲内。菊花择去蒂,薏米洗净;把菊花薏米一起下锅,然后混合锅里鸽子一起顿,大火煮开,小火慢炖20分钟起锅。【功效】:此汤具有利水消肿、健脾去湿、舒筋除痹、清热排脓等功效,薏米使皮肤光滑,减少皱纹,消除色素斑点的功效。对面部粉刺及皮肤粗糙有明显的疗效。比较有利于肠胃的吸收,身体常觉疲倦没力气的人,可以多吃。薏仁中含有丰富的蛋白质分解酵素,能使皮肤角质软化。菊花散风清热,平肝明目。食之可增强毛细血管抵抗力。
(2)荷叶,【别名】莲叶、鲜荷叶、干荷叶、荷叶炭、荷钱、芰荷、藕叶;【拉丁名】Folium Nelumbinis.荷叶系睡莲属植物莲的叶子,它自古以来就是一种药食两用的植物,在1991年1月中华人民共和国卫生部的卫监发(1991)第45号文件中,荷叶被列入第2批“即是食品又是药品” 的名单中。现代药理研究证明荷叶具有多种生理活性,它含有碳水化合物、脂质、蛋白质、多糖、矿物质、β-胡萝卜素、维生素C、构椽酸、酒石酸、苹果酸、草酸等化学成分,黄酮和生物碱等多种活性物质,具有降脂减肥、抗氧化及抗衰老、抑菌、抗病毒、抑制脂肪肝等作用。
(3)莲子,为睡莲科植物莲成熟种子。莲子的营养价值较高,含有丰富的蛋白质、脂肪和碳水化合物,莲子中的钙、磷和钾含量非常丰富,除可以构成骨骼和牙齿的成分外,还有促进凝血,使某些酶活化,维持神经传导性,镇静神经,维持肌肉的伸缩性和心跳的节律等作用。丰富的磷还是细胞核蛋白的主要组成部分,帮助机体进行蛋白质、脂肪、糖类代谢,并维持酸碱平衡,对精子的形成也有重要作用。莲子有养心安神的功效。中老年人特别是脑力劳动者经常食用,可以健脑,增强记忆力,提高工作效率并能预防老年性痴呆的发生。莲子心味道极苦,却有显著的强心作用,能扩张外周血管,降低血压。莲心还有很好的去心火的功效,治疗口舌生疮,助于睡眠。莲子有益心补肾、健脾止泻、固精安神的作用。
(4)龙眼肉,拉丁名:Dimocarpus longan Lour.,本品为无患子科龙眼属植物龙眼的假种皮。夏、秋二季采收成熟果实,干燥,除去壳、核,晒至干爽不黏。别名:桂圆、圆眼。气微香,味甜。龙眼营养丰富,是珍贵的滋养强化剂。果实除鲜食外,还可制成罐头、酒、膏、酱等,亦可加工成桂圆干肉等。此外龙眼的叶、花、根、核均可入药。龙眼树木质坚硬,纹理细致优美,是制作高级家具的原料,又可以雕刻成各种精巧工艺品。龙眼花是一种重要的蜜源植物,龙眼蜜是蜂蜜中的上等蜜。【功效】:1)降脂护心,延缓衰老:桂圆肉可降血脂,增加冠状动脉血流量。对与衰老过程有密切关系的黄素蛋白—脑B型单胺氧化酶(MAO-B)有较强的抑制作用。2)养颜护肤:增强皮肤张力、消除皱纹的功效。3)益气补血,增强记忆:桂圆含丰富的葡萄糖、蔗糖及蛋白质等,含铁量也较高,可在提高热能、补充营养的同时,又能促进血红蛋白再生以补血。实验研究发现,桂圆肉除对全身有补益作用外,对脑细胞特别有益,能增强记忆,消除疲劳。【性味归经】:甘,温;归心、脾经。【功能与主治】:补益心脾,养血安神。用于气血不足,心悸怔忡,健忘失眠,血虚萎黄。【文献选录】:1)、《纲目》:食品以荔枝为贵,而资益则龙眼为良,盖荔枝性热,而龙眼性和平也。严用和《济生方》治思虑劳伤心脾有归脾汤,取甘味归脾,能益人智之义。2)《药品化义》:桂圆,大补阴血,凡上部失血之后,入归脾汤同莲肉、芡实以补脾阴,使脾旺统血归经。如神思劳倦,心经血少,以此助生地、麦冬补养心血。又筋骨过劳,肝脏空虚,以此佐熟地、当归,滋补肝血。
(5)党参,拉丁名:Codonopsis pilosula (Franch.) Nannf.,党参呈椭圆形或类圆形的厚片,表面黄棕色或灰黄色,切面黄白色或黄棕色,有裂隙或菊花纹,中央有淡黄色圆心。周边淡黄白色置黄棕色,有纵皱纹。有特殊香气,味微甜。生党参片益气生津力胜。常用于气津两伤或气血两亏。党参味甘,性平。有补中益气、止渴、健脾益肺,养血生津。用于脾肺气虚,食少倦怠,咳嗽虚喘,气血不足,面色萎黄,心悸气短,津伤口渴,内热消渴。懒言短气、四肢无力、食欲不佳、气虚、气津两虚、气血双亏以及血虚萎黄等症。但表证未解而中满邪实的不能用。该品功效与人参相似,惟药力薄弱。治一般虚证,可代替人参使用;虚脱重证,则仍用人参为宜。秋季采挖,洗净,晒干。产地中国北方海拔1560-3100米的山地林边及灌丛中。【性味归经】:甘,平;归脾,肺经。【功能与主治】:补中益气,健脾益肺。用于脾肺虚弱,气短心悸,食少便溏,虚喘咳嗽,内热消渴。【药理作用】①对血细胞的影响党参根的醇、水浸膏口服或皮下注射,可使正常兔的红细胞及血红蛋白略有增加;摘除脾脏后,作用显着减弱,故推测其"补血"作用,可能与脾脏有关。此时白细胞则有减少倾向。北党参据云无此作用。党参浸液1:40在试管内无溶血现象,但与红细胞作用后,可变色,发生浑浊、沉淀。②对血糖的影响:对兔腹部皮下注射党参浸膏,可使血糖升高;但如注射发酵后的浸膏或灌胃给药,则无比作用,故认为其升高血糖乃因根中含多量糖分所致;它也不能抑制因注射利尿素而发生的神经性高血糖。据初步试验,北党参灌胃,能升高血糖。③降压作用:醇、水浸膏静脉或腹腔注射,能降低麻醉犬的血压,据初步分析,认为是属于末梢性的;并有某些抗肾上腺素作用;其水浸液或醇、水浸出液也有降低麻醉动物血压的作用,并能抑制离体蟾蜍心脏。对慢性高血压犬,每日灌服水浸液4克(生药)/公斤,未见有降压作用。同属植物的根的提取物或总甙,长期(40天)喂兔,可增加红细胞敷(17.5%),增加体重(23%);对松节油引起的白细胞增多症有预防及治疗功效;长期口服,内脏器官未发现有何病理改变。总甙予小鼠口服,小量可增强呼吸,大量可降低水合氯醛之麻醉:对士的宁反似有某些拮抗作用。
(6)决明子,拉丁名:CatsiatoraLinn,为豆科一年生草本植物决明或小决明的干燥成熟种子;别名有马蹄决明、钝叶决明、假绿豆、草决明等;生于村边、路旁和旷野等处。分布于长江以南各省区。全世界热带地方均有。安徽、广西、四川、浙江、广东等省,南北各地均有栽培。决明子药理作用:抗菌作用,抗真菌;降压,降血脂;抗血小板聚集;保护肝脏;缓泻作用;促进胃液分泌。
【性味归经】味甘、苦,性寒,微咸;归肝、大肠经。【功效主治】清热明目,润肠通便。用于目赤涩痛,羞明多泪,头痛眩晕,目暗不明,大便秘结。归肝、肾、大肠经。有减肥之功效。治风热赤眼,青盲,雀目,高血压,肝炎,肝硬化腹水,习惯性便秘。
本发明与已有技术相比,其突出的实质性特点和显著的进步是:
1、本发明优选了一些常用的且具有保健作用的中药药材,科学配伍,各原料相互配合、取长补短、协同作用,制成菊花六宝茶;该保健茶具有排毒养颜、理气止痛;补血通经、润肺祛湿;抗衰老之功效;清肝明目;使人延年益寿;身心健康和标本兼治之功效。
2、本发明能最大化激发菊花和决明子的价值,提高决明子利用价值,能具有清肝明目、降高血压、高血糖、高血脂的功效。
3、本发明具有保护肝脏、气虚可补、瘀血可散;促进消除面上皱纹,使人面上红润,精神换发,增进食欲,共奏益气活血、标本兼治。
具体实施方式
以下是本发明的实施例:
实施例一:
采用以下步骤即可制备得到菊花六堡茶:
(1)按重量份数取菊花8份、荷叶4份、莲子8份、龙眼肉4份、党 参4份和决明子3份。
(2)将莲子、荷叶、龙眼肉和决明子,洗净晒干,去除腐坏颗粒,分别各自粉碎过80-120目筛;
(3)将党参,洗净晒干,切段,粉碎过80-120目筛;
(4)将菊花,用砂锅小火焙干,粉碎过80-120目筛;
(5)将上述的菊花、荷叶、莲子、龙眼肉、党参和决明子的粉末,混合均匀,放入烤箱中,100-120℃烘烤0.5-1.5分钟,自然冷却后装入茶叶袋,即得菊花六宝茶。
实施例二:
采用以下步骤即可制备得到菊花六堡茶:
(1)按重量份数取菊花10份、荷叶6份、莲子10份、龙眼肉7份、党 参7份和决明子4份。
(2)将莲子、荷叶、龙眼肉和决明子,洗净晒干,去除腐坏颗粒,分别各自粉碎过80-120目筛;
(3)将党参,洗净晒干,切段,粉碎过80-120目筛;
(4)将菊花,用砂锅小火焙干,粉碎过80-120目筛;
(5)将上述的菊花、荷叶、莲子、龙眼肉、党参和决明子的粉末,混合均匀,放入烤箱中,100-120℃烘烤0.5-1.5分钟,自然冷却后装入茶叶袋,即得菊花六宝茶。
实施例三:
采用以下步骤即可制备得到菊花六堡茶:
(1)按重量份数取菊花18份、荷叶8份、莲子12份、龙眼肉9份、党 参9份和决明子5份。
(2)将莲子、荷叶、龙眼肉和决明子,洗净晒干,去除腐坏颗粒,分别各自粉碎过80-120目筛;
(3)将党参,洗净晒干,切段,粉碎过80-120目筛;
(4)将菊花,用砂锅小火焙干,粉碎过80-120目筛;
(5)将上述的菊花、荷叶、莲子、龙眼肉、党参和决明子的粉末,混合均匀,放入烤箱中,100-120℃烘烤0.5-1.5分钟,自然冷却后装入茶叶袋,即得菊花六宝茶。
本发明菊花六宝茶对具有、容易疲倦长痘、睡眠质量、溃疡以及咽痛的病例进行治疗,以100例具有为治疗,其中90例有明显治疗效果,10例相对好转,证明其具有润肺、养胃、清肝,滋肾益气,生精助阳,补虚劳,强筋骨等作用。
应用实施例:
1、朱某,女,35岁,平素性格内向,爱生闷气,易发烦躁,经常面对电脑、眼睛干涩,乳房胀痛。服用本发明的菊花六宝茶一个星期后,症状减轻;再继续服用一个星期后,症状消除,恢复正常生活。对于肝火旺或是经常对电脑用眼过度的有很好的效果。
2、黄某某,女,52岁,患有高血脂,伴有头晕目眩、头痛、胸闷、气短、心慌、胸痛、乏力等症状,靠服用西药,症状稍有缓解,血脂有一定下降和得到控制,但饮食稍不注意,血脂升高,没能得到彻底治疗,后经人介绍服用本发明的菊花六宝茶,连续服用3个月,症状有消除,饮食能多样化,血脂恢复正常。
3、李某某,女,56岁,患有高血糖,依赖于注射胰岛素来控制血压,而注射胰岛素费用高,无力长期注射,且胰岛素只起控制,并不能进行有效治疗;后经他人介绍服用本发明的菊花六宝茶,连续服用3个月,血糖逐渐回落至正常水平,呼吸顺畅,精神状态好。
4、黄某某,女,32岁,因工作压力大;睡眠不足;气色不佳,脸上长有痘痘和长斑,皮肤粗糙,脸部皱纹增多。服用本发明的菊花六宝茶一个星期后,症状均减轻,睡眠质量好,气色饱满;再继续服用一个星期后,症状全部消除,恢复正常生活。
Claims (3)
1.一种菊花六宝茶,其特征在于:该菊花六宝茶是由以下重量份的原料制成的:菊花8~18份、荷叶4~8份、莲子8~12份、龙眼肉4~9份、党 参4~9份和决明子3~5份。
2.根据权利要求1所述的菊花六宝茶,其特征在于:菊花六宝茶的制备过程为:
(1)将莲子、荷叶、龙眼肉和决明子,洗净晒干,去除腐坏颗粒,分别各自粉碎过80-120目筛;
(2)将党参,洗净晒干,切段,粉碎过80-120目筛;
(3)将菊花,用砂锅小火焙干,粉碎过80-120目筛;
(4)将上述的菊花、荷叶、莲子、龙眼肉、党参和决明子的粉末,混合均匀,装入茶叶袋,即得菊花六宝茶。
3.根据权利要求1所述的菊花六宝茶,其特征在于:步骤(4)中混合均匀后的粉末放入烤箱中,100-120℃烘烤0.5-1.5分钟,待自然冷却后即可包装。
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201911119732.1A CN110692787A (zh) | 2019-11-15 | 2019-11-15 | 菊花六宝茶及其制备方法 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201911119732.1A CN110692787A (zh) | 2019-11-15 | 2019-11-15 | 菊花六宝茶及其制备方法 |
Publications (1)
Publication Number | Publication Date |
---|---|
CN110692787A true CN110692787A (zh) | 2020-01-17 |
Family
ID=69206210
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201911119732.1A Pending CN110692787A (zh) | 2019-11-15 | 2019-11-15 | 菊花六宝茶及其制备方法 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN110692787A (zh) |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN114947030A (zh) * | 2021-02-25 | 2022-08-30 | 陕西罗麻丹医药有限公司 | 一种改善肝功能的固体饮料及其制备方法 |
Citations (11)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN101731607A (zh) * | 2008-11-05 | 2010-06-16 | 卢松峰 | 具有提神作用的保健茶及其制备方法 |
CN101864355A (zh) * | 2010-06-29 | 2010-10-20 | 饶峰 | 一种含雪莲的保健酒和保健茶及其制备方法 |
CN103535463A (zh) * | 2012-10-08 | 2014-01-29 | 杭州艺福茶业有限公司 | 一种玫瑰荷叶袋泡茶及其制备方法 |
CN104904931A (zh) * | 2015-05-05 | 2015-09-16 | 禹州市鼎信中药科技有限公司 | 一种菊花决明代用茶及其制备方法 |
CN105053386A (zh) * | 2015-07-13 | 2015-11-18 | 安徽英华药业有限公司 | 一种杞果菊花茶及其制备方法 |
CN105309714A (zh) * | 2015-11-27 | 2016-02-10 | 张家港市桃源食品有限公司 | 一种菊花茶 |
CN105454576A (zh) * | 2015-12-08 | 2016-04-06 | 陈艳影 | 茉莉花八宝茶及其制备方法 |
CN106070873A (zh) * | 2016-06-17 | 2016-11-09 | 亳州市益众堂保健食品有限公司 | 一种枸杞菊花茶及其制作方法 |
CN106387158A (zh) * | 2016-08-19 | 2017-02-15 | 江西汇仁药业股份有限公司 | 一种保健茶及其制备方法 |
CN108740191A (zh) * | 2018-05-28 | 2018-11-06 | 何永峰 | 一种枸杞子菊花代用茶 |
CN109329520A (zh) * | 2018-11-28 | 2019-02-15 | 江苏新岚实业有限公司 | 一种桑叶菊花茶的生产工艺 |
-
2019
- 2019-11-15 CN CN201911119732.1A patent/CN110692787A/zh active Pending
Patent Citations (11)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN101731607A (zh) * | 2008-11-05 | 2010-06-16 | 卢松峰 | 具有提神作用的保健茶及其制备方法 |
CN101864355A (zh) * | 2010-06-29 | 2010-10-20 | 饶峰 | 一种含雪莲的保健酒和保健茶及其制备方法 |
CN103535463A (zh) * | 2012-10-08 | 2014-01-29 | 杭州艺福茶业有限公司 | 一种玫瑰荷叶袋泡茶及其制备方法 |
CN104904931A (zh) * | 2015-05-05 | 2015-09-16 | 禹州市鼎信中药科技有限公司 | 一种菊花决明代用茶及其制备方法 |
CN105053386A (zh) * | 2015-07-13 | 2015-11-18 | 安徽英华药业有限公司 | 一种杞果菊花茶及其制备方法 |
CN105309714A (zh) * | 2015-11-27 | 2016-02-10 | 张家港市桃源食品有限公司 | 一种菊花茶 |
CN105454576A (zh) * | 2015-12-08 | 2016-04-06 | 陈艳影 | 茉莉花八宝茶及其制备方法 |
CN106070873A (zh) * | 2016-06-17 | 2016-11-09 | 亳州市益众堂保健食品有限公司 | 一种枸杞菊花茶及其制作方法 |
CN106387158A (zh) * | 2016-08-19 | 2017-02-15 | 江西汇仁药业股份有限公司 | 一种保健茶及其制备方法 |
CN108740191A (zh) * | 2018-05-28 | 2018-11-06 | 何永峰 | 一种枸杞子菊花代用茶 |
CN109329520A (zh) * | 2018-11-28 | 2019-02-15 | 江苏新岚实业有限公司 | 一种桑叶菊花茶的生产工艺 |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN114947030A (zh) * | 2021-02-25 | 2022-08-30 | 陕西罗麻丹医药有限公司 | 一种改善肝功能的固体饮料及其制备方法 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN103918830B (zh) | 一种暖茶饮料 | |
CN104957298A (zh) | 养生茉莉花茶 | |
CN105695258A (zh) | 一种含荔枝核皂苷的女性保健酒 | |
CN106359746A (zh) | 一种葛根凉茶及其制备方法 | |
CN104225361A (zh) | 一种丹七养生酒及其制备方法 | |
CN102940153A (zh) | 一种改善肉质、蛋质的家禽饲料 | |
CN101129826B (zh) | 中药保健枕 | |
CN105454576A (zh) | 茉莉花八宝茶及其制备方法 | |
CN106035860A (zh) | 一种减肥降压养生袋装茶及其制备方法 | |
CN110810595A (zh) | 一种减脂养生茶及其制备方法 | |
KR20160000695A (ko) | Dha 함유 기억력 강화 및 피로회복 증진용 한약재 조성물 수능환 및 그 제조방법 | |
CN103749839A (zh) | 一种灵芝万寿果茶 | |
CN106962921A (zh) | 一种健康饮食添加粉及其制备方法 | |
CN106262756A (zh) | 干菜花生米辣椒酱及其制备方法 | |
CN110692787A (zh) | 菊花六宝茶及其制备方法 | |
CN103520302B (zh) | 一种沙棘叶抗疲劳胶囊及其制备方法 | |
CN108576341A (zh) | 一种可改善男性性功能的咖啡及制备方法 | |
KR101783549B1 (ko) | Dha 함유 피로회복 증진 보조식품용 조성물 수능단(수능원) 및 그 제조방법 | |
CN106173010A (zh) | 一种护肝养生的牛樟茶及其加工工艺 | |
CN114748583A (zh) | 一种滋补养生的中药药酒 | |
CN102670974B (zh) | 一种养生保健酒 | |
CN111406938A (zh) | 一种含九蒸九晒黑芝麻的纯手工阿胶糕 | |
CN110692777A (zh) | 养生玫瑰花茶及其生产方法 | |
CN104645123A (zh) | 一种防治慢性肾功能衰竭的丸剂及制备方法 | |
CN104498298B (zh) | 一种高粱酒及其制备方法 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
RJ01 | Rejection of invention patent application after publication | ||
RJ01 | Rejection of invention patent application after publication |
Application publication date: 20200117 |